Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden · Delayed Price · Currency is SEK 3.500
+0.060 (1.74%)
At close: Feb 10, 2026
Scandinavian ChemoTech AB Revenue
Scandinavian ChemoTech AB had revenue of 3.32M SEK in the quarter ending September 30, 2025, with 121.75% growth. This brings the company's revenue in the last twelve months to 11.68M, up 132.07% year-over-year. In the year 2024, Scandinavian ChemoTech AB had annual revenue of 6.57M with 132.67% growth.
Revenue (ttm)
11.68M
Revenue Growth
+132.07%
P/S Ratio
7.00
Revenue / Employee
11.68M
Employees
1
Market Cap
81.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.57M | 3.74M | 132.67% |
| Dec 31, 2023 | 2.82M | 2.35M | 496.62% |
| Dec 31, 2022 | 473.00K | -2.11M | -81.70% |
| Dec 31, 2021 | 2.59M | 1.17M | 82.81% |
| Dec 31, 2020 | 1.41M | -3.24M | -69.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alligator Bioscience AB | 46.22M |
| Alzinova AB | 26.12M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| Biovica International AB | 9.89M |
| Spago Nanomedical AB | 5.84M |
| OncoZenge AB | 2.78M |
| Simris Group AB (PUBL) | 2.30M |
| Pila Pharma AB | 957.89K |